Bengt Hamrén
Impact in
- Statistics and Probability top 2%
- Statistical Methods in Clinical Trials
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Diabetes Treatment and Management 12
- Surgery 9
- Pancreatic function and diabetes 5
- Lipoproteins and Cardiovascular Health 4
- Co-authors
- Ulf G. Eriksson (3 shared papers)Mark Fidock (1 shared paper)James Matcham (2 shared papers)Anthony Johnson (1 shared paper)Dean G. Brown (1 shared paper)Paul Morgan (1 shared paper)Ruth March (1 shared paper)Simon Lennard (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (6 papers)The Journal of Clinical Pharmacology (5 papers)CPT Pharmacometrics & Systems Pharmacology (4 papers)Clinical Pharmacokinetics (3 papers)Clinical Pharmacology & Therapeutics (3 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Bengt Hamrén
39 papers receiving 954 citations
Bengt Hamrén's Hit Papers
Peers
Comparison fields: 5 of 114
- Statistics and Probability 159
- Pharmacology 92
- Computational Theory and Mathematics 170
- Endocrinology, Diabetes and Metabolism 125
- Molecular Biology 282
Countries citing papers authored by Bengt Hamrén
This map shows the geographic impact of Bengt Hamrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Hamrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Hamrén more than expected).
Fields of papers citing papers by Bengt Hamrén
This network shows the impact of papers produced by Bengt Hamrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Hamrén. The network helps show where Bengt Hamrén may publish in the future.
Co-authors
The 25 scholars most cited alongside Bengt Hamrén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Impact of a five-dimensional framework on R&D productivity at AstraZeneca Hit paper breakdown → | 2018 | 278 |
| 2 | Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation Hit paper breakdown → | 2015 | 264 |
| 3 | 2008 | 50 | |
| 4 | 2012 | 42 | |
| 5 | 2010 | 32 | |
| 6 | 2017 | 31 | |
| 7 | 2017 | 25 | |
| 8 | Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. | 2004 | 23 |
| 9 | 2016 | 19 | |
| 10 | 2011 | 17 | |
| 11 | 2019 | 17 | |
| 12 | 2016 | 16 | |
| 13 | 2005 | 16 | |
| 14 | 2018 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2004 | 12 | |
| 17 | 2008 | 11 | |
| 18 | 2014 | 11 | |
| 19 | 2019 | 10 | |
| 20 | 2017 | 9 |
About Bengt Hamrén
Bengt Hamrén is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Economics and Econometrics and Statistics and Probability, having authored 42 papers that have together received 981 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (12 papers), Statistical Methods in Clinical Trials (7 papers), Pharmaceutical Economics and Policy (5 papers), Pancreatic function and diabetes (5 papers), Computational Drug Discovery Methods (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). The work is most often cited by research in Statistics and Probability (159 citations), Pharmacology (92 citations), Computational Theory and Mathematics (170 citations), Endocrinology, Diabetes and Metabolism (125 citations) and Molecular Biology (282 citations). Bengt Hamrén has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Ulf G. Eriksson, Mark Fidock, James Matcham, Anthony Johnson, Dean G. Brown, Paul Morgan, Ruth March, Simon Lennard, David Nicholls and Michael Snowden. Their work appears in journals such as British Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacokinetics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.